Modernizing Clinical Trials Requires Agility

In COVID-19, Latest News by Precision Vaccinations

The U.S. Food and Drug Administration (FDA) announced updated recommendations for good clinical practices (GCPs) to modernize the design and conduct of clinical trials, making them more agile without compromising data integrity or participant protections.
Proposed in June 2023, the draft guidance is adopted from the International Council for Harmonisation's (ICH) recently updated E6(R3) draft guideline developed to enable the incorporation of rapidly evolving technological and methodological innovations into the clinical trial enterprise. 

Read More